Yu-Waye Chu

Companies

• CytomX Therapeutics, Inc.Chief Medical Officer Jul 20, 2023 to now¹
• Fate TherapeuticsOfficer Apr 2, 2021 to Apr 19, 2023²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• CTCytomX Therapeutics, Inc. CTMX189,446 shares³$431.9K at $2.28Mar 17, 2026
• FTFate Therapeutics FATE140,676 shares⁴$251.8K at $1.79Apr 18, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 17, 2026Sold 21,279 shares at $6.42 of CytomX Therapeutics, Inc.³
• Feb 2, 2026Granted 75,000 shares of CytomX Therapeutics, Inc.⁵
• Mar 18, 2025Sold 4,025 shares at $0.60 of CytomX Therapeutics, Inc.⁶
• Feb 4, 2025Granted 57,500 shares of CytomX Therapeutics, Inc.⁷
• Feb 4, 2025Granted 56,000 shares of CytomX Therapeutics, Inc.⁷
• Jan 18, 2024Granted 26,250 shares of CytomX Therapeutics, Inc.⁸
• Apr 18, 2023Sold 2,317 shares at $6.58 of Fate Therapeutics⁴
• Apr 18, 2023Sold 215 shares at $6.52 of Fate Therapeutics⁴
• Jan 10, 2023Sold 7,825 shares at $5.24 of Fate Therapeutics⁹
• Apr 19, 2022Sold 4,062 shares at $35.37 of Fate Therapeutics¹⁰
• Jan 25, 2022Granted 33,302 shares of Fate Therapeutics¹¹
• Jan 11, 2022Sold 418 shares at $49.10 of Fate Therapeutics¹²
• Jan 11, 2022Sold 3,547 shares at $48.44 of Fate Therapeutics¹²
• Dec 10, 2021Sold 5 shares at $55.54 of Fate Therapeutics¹³
• Dec 10, 2021Sold 600 shares at $54.58 of Fate Therapeutics¹³
• Dec 10, 2021Sold 1,031 shares at $53.66 of Fate Therapeutics¹³
• Dec 10, 2021Sold 1,822 shares at $52.37 of Fate Therapeutics¹³
• Dec 10, 2021Sold 1,045 shares at $51.08 of Fate Therapeutics¹³
• Dec 10, 2021Sold 900 shares at $50.42 of Fate Therapeutics¹³
• Dec 10, 2021Sold 2,097 shares at $49.32 of Fate Therapeutics¹³
• Dec 10, 2021Exercised options 7,500 shares at $16.32 of Fate Therapeutics¹³
• Nov 19, 2021Granted 60,958 shares of Fate Therapeutics¹⁴